Extract of Polygala tenuifolia, Angelica tenuissima, and Dimocarpus longan Reduces Behavioral Defect and Enhances Autophagy in Experimental Models of Parkinson’s Disease
- 11 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in NeuroMolecular Medicine
- Vol. 23 (3), 428-443
- https://doi.org/10.1007/s12017-020-08643-x
Abstract
The 20% ethanol extract of Polygala tenuifolia, Angelica tenuissima, and Dimocarpus longan (WIN-1001X) was derived from a modified version of Korean traditional herbal formula ‘Chungsimyeolda-tang’ which has been used for the treatment of cerebrovascular disorders. The Parkinson’s disease presents with impaired motor functions and loss of dopaminergic neurons. However, the treatment for Parkinson’s disease is not established until now. This study aims to elucidate the therapeutic advantages of WIN-1001X on animal models of Parkinson’s disease. WIN-1001X administration successfully relieved the Parkinsonism symptoms in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson’s disease mice tested by rota-rod and pole tests. The loss of tyrosine hydroxylase activities in substantia nigra and striatum was also attenuated by administration of WIN-1001X. In mice with sub-chronical MPTP injections, autophagy-related proteins, such as LC3, beclin-1, mTOR, and p62, were measured using the immunoblot assay. The results were favorable to induction of autophagy after the WIN-1001X administration. WIN-1001X treatment on 6-hydroxydopamine-injected rats also exhibited protective effects against striatal neuronal damage and loss of dopaminergic cells. Such protection is expected to be due to the positive regulation of autophagy by administration of WIN-1001X with confirmation both in vivo and in vitro. In addition, an active compound, onjisaponin B was isolated and identified from WIN-1001X. Onjisaponin B also showed significant autophagosome-inducing effect in human neuroblastoma cell line. Our study suggests that relief of Parkinsonism symptoms and rescue of tyrosine hydroxylase activity in dopaminergic neurons are affected by autophagy enhancing effect of WIN-1001X which the onjisaponin B is one of the major components of activity.Keywords
Funding Information
- National Research Foundation of Republic of Korea (NFR-2012M3A9C4048793)
- Korea Health Industry Development Institute (HI18C1860)
This publication has 35 references indexed in Scilit:
- Onjisaponin B Derived from Radix Polygalae Enhances Autophagy and Accelerates the Degradation of Mutant α-Synuclein and Huntingtin in PC-12 CellsInternational Journal of Molecular Sciences, 2013
- The Role of Autophagy in Parkinson's DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- The dopamine-D2-receptor agonist ropinirole dose-dependently blocks the Ca2+-triggered permeability transition of mitochondriaBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- The emerging role of autophagy in Parkinson's diseaseMolecular Brain, 2009
- Characterization of Behavioral and Neurodegenerative Changes Following Partial Lesions of the Nigrostriatal Dopamine System Induced by Intrastriatal 6-Hydroxydopamine in the RatExperimental Neurology, 1998
- Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the ratNeuroscience, 1994
- MPTP Toxicity: Implications for Research in Parkinson's DiseaseAnnual Review of Neuroscience, 1988
- MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease.Environmental Health Perspectives, 1987
- Studies on the constituents of the root of Polygala tenuifolia Willdenow. II. On the structures of onjisaponins A, B and E.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- 6-hydroxy-dopamine induced degeneration of central monoamine neuronsEuropean Journal of Pharmacology, 1968